Ceruletide and neostigmine in postoperative intestinal paralysis. A double-blind clinical controlled trial.
A double-blind and randomized clinical trial, which included 48 patients with postoperative intestinal paralysis on the third day after laparotomy, demonstrated no difference between treatment with ceruletide (0.3 microgram/kg body weight) and neostigmine (5.0 micrograms/kg body weight) in restoring normal intestinal function.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002108:Ceruletide / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D007410:Intestinal Diseases / Q000188:drug therapy*; D008875:Middle Aged; D009388:Neostigmine / Q000627:therapeutic use*; D010243:Paralysis / Q000188:drug therapy*; D011183:Postoperative Complications / Q000188:drug therapy*
D009388:Neostigmine; D002108:Ceruletide